Stock Earnings

Question 1

What are OSE Immunotherapeutics SA's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), OSE Immunotherapeutics SA has a total asset of $123, Net profit of $37

Question 2

What are the key financial ratios for ORPOF?

Accepted Answer

OSE Immunotherapeutics SA's Current ratio is 2.05, has a Net margin is 44.57, sales per share of $3.79.

Question 3

How is OSE Immunotherapeutics SA's revenue broken down by segment or geography?

Accepted Answer

OSE Immunotherapeutics SA largest revenue segment is Research and Development on Pharmaceutical Products, at a revenue of 2,227,000 in the most earnings release.For geography, France is the primary market for OSE Immunotherapeutics SA, at a revenue of 2,227,000.

Question 4

Is OSE Immunotherapeutics SA profitable?

Accepted Answer

yes, according to the latest financial statements, OSE Immunotherapeutics SA has a net profit of $37

Question 5

Does OSE Immunotherapeutics SA have any liabilities?

Accepted Answer

yes, OSE Immunotherapeutics SA has liability of 60

Question 6

How many outstanding shares for OSE Immunotherapeutics SA?

Accepted Answer

OSE Immunotherapeutics SA has a total outstanding shares of 21.89

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	2	83	2	18	26	10
Revenue Growth (YoY)	-98%	4,050%	-89%	-31%	160%	-60%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	10	9	7	8	11	6
Research & Development	33	32	24	29	33	27
Operating Expenses	37	39	25	36	42	29
Other Non Operating Income (Expenses)	0	1	0	0	0	0
Pretax Income	-35	39	-23	-18	-17	-19
Income Tax Expense	-1	2	0	0	0	-2
Net Income	-34	37	-23	-17	-16	-16
Net Income Growth	-174%	-261%	35%	6%	0%	300%
Shares Outstanding (Diluted)	22.11	21.89	19.56	18.52	18.15	15.55
Shares Change (YoY)	-12%	12%	6%	2%	17%	4%
EPS (Diluted)	-1.58	1.71	-1.17	-0.95	-0.92	-1.06
EPS Growth	-187%	-245%	23%	3%	-13%	241%
Free Cash Flow	-37	48	-19	-18	-10	-19
Free Cash Flow Per Share	-1.67	2.19	-0.97	-0.97	-0.55	-1.22
Gross Margin	--	--	--	--	--	--
Operating Margin	-1,750%	51.8%	-1,150%	-100%	-61.53%	-180%
Profit Margin	-1,700%	44.57%	-1,150%	-94.44%	-61.53%	-160%
Free Cash Flow Margin	-1,850%	57.83%	-950%	-100%	-38.46%	-190%
EBITDA	-32	46	-20	-15	-14	-18
EBITDA Margin	-1,600%	55.42%	-1,000%	-83.33%	-53.84%	-180%
D&A For EBITDA	3	3	3	3	2	0
EBIT	-35	43	-23	-18	-16	-18
EBIT Margin	-1,750%	51.8%	-1,150%	-100%	-61.53%	-180%
Effective Tax Rate	2.85%	5.12%	0%	0%	0%	10.52%

OSE Immunotherapeutics SA (ORPOF) Price

ORPOF Stock Price Chart

ORPOF Income

Follow-Up Questions